NEW YORK CITY, NY / ACCESS Newswire / September 28, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Evolv Technologies Holdings, Inc. ("Evolv Technologies" or "the Company") (NASDAQ:EVLV). Investors who purchased Evolv Technologies securities prior to August 19, 2022, and continue to hold to the present, are […]

NEW YORK CITY, NY / ACCESS Newswire / September 28, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Paragon 28, Inc. ("Paragon 28" or "the Company") (NYSE:FNA). Investors who purchased Paragon 28 securities prior to May 5, 2023, and continue to hold to the present, are encouraged

NEW YORK CITY, NY / ACCESS Newswire / September 28, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Extreme Networks, Inc. ("Extreme Networks" or "the Company") (NASDAQ:EXTR). Investors who purchased Extreme Networks securities prior to July 27, 2022, and continue to hold to the present, are encouraged

NEW YORK, NY / ACCESS Newswire / September 28, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Sharecare Inc. ("Sharecare" or "the Company") (NASDAQ:SHCR). Investors who purchased Sharecare securities prior to May 10, 2023, and continue to hold to the present, are encouraged to obtain additional information

NEW YORK CITY, NY / ACCESS Newswire / September 28, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of America’s Car-Mart, Inc. ("Car-Mart" or "the Company") (NASDAQ:CRMT). Investors who purchased Car-Mart securities are encouraged to obtain additional information and assist the investigation by visiting the firm’s site: bgandg.com/CRMT.

NEW YORK, NY / ACCESS Newswire / September 28, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Applied Therapeutics, Inc. ("Applied Therapeutics" or "the Company") (NASDAQ:APLT). Investors who purchased Applied Therapeutics securities prior to January 3, 2024, and continue to hold to the present, are encouraged to

NEW YORK CITY, NY / ACCESS Newswire / September 28, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Avis Budget Group, Inc. ("Avis Budget" or "the Company") (NASDAQ:CAR). Investors who purchased Avis Budget securities prior to February 13, 2024, and continue to hold to the present, are

NEW YORK CITY, NY / ACCESS Newswire / September 28, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Ibotta, Inc. ("Ibotta" or "the Company") (NYSE:IBTA). Investors who purchased Ibotta securities prior to April 18, 2024, and continue to hold to the present, are encouraged to obtain additional

NEW YORK CITY, NY / ACCESS Newswire / September 28, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of MGP Ingredients, Inc. ("MGP Ingredients" or "the Company") (NASDAQ:MGPI). Investors who purchased MGP Ingredients securities prior to May 4, 2023, and continue to hold to the present, are encouraged

NEW YORK CITY, NY / ACCESS Newswire / September 28, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Manhattan Associates, Inc. ("Manhattan Associates" or "the Company") (NASDAQ:MANH). Investors who purchased Manhattan Associates securities prior to October 22, 2024, and continue to hold to the present, are encouraged